Insmed Valuation

INSM Stock  USD 73.15  0.66  0.89%   
At this time, the firm appears to be overvalued. Insmed Inc retains a regular Real Value of $57.45 per share. The prevalent price of the firm is $73.15. Our model calculates the value of Insmed Inc from evaluating the firm fundamentals such as Return On Asset of -0.26, return on equity of -8.91, and Current Valuation of 12.62 B as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Insmed's valuation include:
Price Book
27.0714
Enterprise Value
12.6 B
Enterprise Value Ebitda
(6.05)
Price Sales
38.1585
Enterprise Value Revenue
36.7937
Overvalued
Today
73.15
Please note that Insmed's price fluctuation is very steady at this time. Calculation of the real value of Insmed Inc is based on 3 months time horizon. Increasing Insmed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Insmed stock is determined by what a typical buyer is willing to pay for full or partial control of Insmed Inc. Since Insmed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Insmed Stock. However, Insmed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  73.15 Real  57.45 Target  42.58 Hype  73.18 Naive  75.17
The intrinsic value of Insmed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Insmed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
57.45
Real Value
80.47
Upside
Estimating the potential upside or downside of Insmed Inc helps investors to forecast how Insmed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Insmed more accurately as focusing exclusively on Insmed's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
-1.42-1.23-1.17
Details
Hype
Prediction
LowEstimatedHigh
70.6773.1875.69
Details
Naive
Forecast
LowNext ValueHigh
72.6675.1777.67
Details
18 Analysts
Consensus
LowTarget PriceHigh
38.7542.5847.26
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Insmed's intrinsic value based on its ongoing forecasts of Insmed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Insmed's closest peers.

Insmed Cash

506.49 Million

Insmed Valuation Trend

Knowing Insmed's actual value is paramount for traders when making sound investment determinations. Using both Insmed's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.

Insmed Total Value Analysis

Insmed Inc is currently projected to have valuation of 12.62 B with market capitalization of 13.09 B, debt of 1.2 B, and cash on hands of 554.87 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Insmed fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
12.62 B
13.09 B
1.2 B
554.87 M

Insmed Investor Information

About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 5.55. Insmed Inc had not issued any dividends in recent years. The entity had 1:10 split on the 3rd of March 2011. Based on the measurements of operating efficiency obtained from Insmed's historical financial statements, Insmed Inc may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.

Insmed Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Insmed has an asset utilization ratio of 22.95 percent. This suggests that the Company is making $0.23 for each dollar of assets. An increasing asset utilization means that Insmed Inc is more efficient with each dollar of assets it utilizes for everyday operations.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Insmed Ownership Allocation

The majority of Insmed Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Insmed to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Insmed Inc. Please pay attention to any change in the institutional holdings of Insmed Inc as this could imply that something significant has changed or is about to change at the company. On July 9, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of Insmed Inc's common stock.

Insmed Profitability Analysis

The company reported the previous year's revenue of 305.21 M. Net Loss for the year was (749.57 M) with profit before overhead, payroll, taxes, and interest of 190.23 M.

About Insmed Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Insmed Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Insmed Inc based exclusively on its fundamental and basic technical indicators. By analyzing Insmed's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Insmed's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Insmed. We calculate exposure to Insmed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Insmed's related companies.
Last ReportedProjected for Next Year
Gross Profit239.6 M251.6 M
Pretax Profit Margin(2.45)(2.57)
Operating Profit Margin(2.33)(2.44)
Net Loss(2.46)(2.58)
Gross Profit Margin 0.79  0.82 

Insmed Growth Indicators

Investing in growth stocks can be very risky. If the company such as Insmed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding140.4 M

Insmed Current Valuation Indicators

Insmed's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Insmed's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Insmed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Insmed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Insmed's worth.
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.55)
Revenue Per Share
2.206
Quarterly Revenue Growth
0.182
Return On Assets
(0.26)
Return On Equity
(8.91)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.